KARAMBIOSCIENCE
EST. 2026
EVIDENCE / 02
Cell Reports Medicine / 2026-10-01

Temporary instructions. A specific tissue.

Animal intervention · Preclinical repair

AI-generated cellular concept illustration
Concept illustration · not experimental data

What was reported

Liver-targeted lipid nanoparticles carrying reprogramming-factor mRNA enhanced regeneration in experimental acute liver injury. The work is relevant to control of where and for how long reprogramming instructions act.

Read the primary source ↗

What the study measured

Regeneration and recovery after experimental acute liver injury.

Sample and setting

Mouse models of acute liver injury; sample sizes not extracted.

What this does not establish

Recovery after acute injury is not reversal of normal aging. The finding is preclinical and does not establish safe human liver rejuvenation. Online publication is October 1; the issue date is later.

The next question

Can tissue specificity, reversibility, and long-term identity stability be demonstrated independently of acute injury recovery?

This is Karam’s proposed follow-up question, not a claim that the original authors or Karam have already resolved it.

The source record

Enhanced liver regeneration via targeted mRNA delivery for partial in vivo reprogramming

Beom-Ki Jo, Young Seok Song, Woohyun Song, et al.
Cell Reports Medicine · 2026-10-01

DOI: 10.1016/j.xcrm.2026.103084

Publisher metadata and indexed excerpts checked. Full text was not reviewed.

Keep exploring

A research question, not a treatment recommendation

What would this evidence change?

Evidence / Scope an engagement

Karam Evidence Sprint

One question. A source trail. A decision you can explain.

Scope & deliverables↗
Evidence / Scope an engagement

Karam Research Watch

Know what changed—not just what was published.

Scope & deliverables↗